Common data elements for clinical research in Friedreich's ataxia.
Common data elements for clinical research in Friedreich's ataxia.
复制标题
DOI:
10.1002/mds.25201
复制
发表时间:
2013-02
影响因子:
8.6
通讯作者:
Kaufmann, Petra
中科院分区:
文献类型:
--
作者:
Lynch, David R.;Pandolfo, Massimo;Schulz, Jorg B.;Perlman, Susan;Delatycki, Martin B.;Payne, R. Mark;Shaddy, Robert;Fischbeck, Kenneth H.;Farmer, Jennifer;Kantor, Paul;Raman, Subha V.;Hunegs, Lisa;Odenkirchen, Joanne;Miller, Kristy;Kaufmann, Petra
To reduce study start-up time, increase data sharing, and assist investigators conducting clinical studies, the National Institute of Neurological Disorders and Stroke embarked on an initiative to create common data elements for neuroscience clinical research. The Common Data Element Team developed general common data elements which are commonly collected in clinical studies regardless of therapeutic area, such as demographics. In the present project, we applied such approaches to data collection in Friedreich ataxia, a neurological disorder that involves multiple organ systems. To develop Friedreich’s ataxia common data elements, Friedreich’s ataxia experts formed a working group and subgroups to define elements in: Ataxia and Performance Measures; Biomarkers; Cardiac and Other Clinical Outcomes; and Demographics, Laboratory Tests and Medical History. The basic development process included: Identification of international experts in Friedreich’s ataxia clinical research; Meeting via teleconference to develop a draft of standardized common data elements recommendations; Vetting of recommendations across the subgroups; Dissemination of recommendations to the research community for public comment. The full recommendations were published online in September 2011 at http://www.commondataelements.ninds.nih.gov/FA.aspx. The Subgroups’ recommendations are classified as core, supplemental or exploratory. Template case report forms were created for many of the core tests. The present set of data elements should ideally lead to decreased initiation time for clinical research studies and greater ability to compare and analyze data across studies. Their incorporation into new and ongoing studies will be assessed in an ongoing fashion to define their utility in Friedreich’s ataxia.
登录
查看更多内容
影响因子:
3.5
作者:
Coppola G;Marmolino D;Lu D;Wang Q;Cnop M;Rai M;Acquaviva F;Cocozza S;Pandolfo M;Geschwind DH
通讯作者:
Geschwind DH
影响因子:
4.2
作者:
Adelson, P. David;Pineda, Jose;Wainwright, Mark S.
通讯作者:
Wainwright, Mark S.
影响因子:
8.6
作者:
Buerk, Katrin;Maelzig, Ulrike;Schulz, Joerg B.
通讯作者:
Schulz, Joerg B.
影响因子:
3.7
作者:
Marmolino D;Manto M;Acquaviva F;Vergara P;Ravella A;Monticelli A;Pandolfo M
通讯作者:
Pandolfo M
影响因子:
9.9
作者:
FINOCCHIARO, G;BAIO, G;DIDONATO, S
通讯作者:
DIDONATO, S